Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Kymera Therapeutics, Inc. Common Stock | KYMR

Daily Technical Analysis of Kymera Therapeutics, Inc. Common Stock

Kymera Therapeutics had a rough day and is now down -7.91%. Investors weren't too impressed with the future outlook for the Biotechnology company which caused some selling on weak demand. It looks like KYMR may be interacting with a downward sloping Support line. It may find or support at this level or it's momentum can continue downward. The Biotechnology company has been chopping around the last few months without a clear directional momentum. So it might bounce off here, but hard to say.

If the price bounces off of the support and moves up it'll probably head up to the $26.24 level, at which point it may hit some selling pressure. If it fails to bounce off this level and breaks down lower, it will most likely find the nearest support a the $16.73 at which point, it may have a chance of recovering from there.


Analyst Ratings for Kymera Therapeutics By Price Target And Rating

Kymera Therapeutics has an overall positive view by the analysts. The current Analysts Sentiment Score is 130.20. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2023-02-24 HC Wainwright reiterated their rating of Buy and added a price target of $85.00. On 2023-02-24 Credit Suisse Group increased their price target by 21.88% to $39.00. Wells Fargo & Company boosted their price targ by 5% to $42.00 on 2023-01-03. Morgan Stanley gave a boost to their price target and moved to $41.00 from $38.00 on 2022-12-19. On 2022-12-16 The Goldman Sachs Group increased their price target by 30% to $52.00. B. Riley gave a boost to their price target and moved to $37.00 from $35.00 on 2022-12-15. SVB Leerink boosted their price targ by 19.23% to $31.00 on 2022-12-15. Piper Sandler gave a boost to their price target and moved to $58.00 from $43.00 on 2022-12-14. Raymond James initiated a rating of Market Perform on 2022-11-08. Jefferies Financial Group initiated a rating of Buy on 2022-08-15 and provided a price target of $40.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
KYMR130.2082.49-0.45178.360

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2022-11-28)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
KYMR-1.62-0.70

Short interest for Kymera Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
KYMR15.31%18.410.68.3168050000

How Kymera Therapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
354-0.271.802.8413.3413.8815.8158.77-14.14-10.57-9.88-28374.34-6755.493.673.886.6351.67
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
593-0.111.531.379.769.846.2758.86-14.04-10.26-11.36-26226.85-6830.393.924.435.9838.86

Social Sentiment for Kymera Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
KYMR9.00

Companies with the highest correlation to Kymera Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
PRTA | Prothena Corporation plc 0.89-3.241.36-4.8042.6717.41148.497036.0038.4769.29-553.94-23334.36004.3338
VCYT | Veracyte, Inc.0.84-1.82-0.869.8012.57-3.2839.575110.029.273.58-3502.95-9166.41004.12529
VRNS | Varonis Systems, Inc.0.83-0.15-0.308.081.6426.38-24.78532.222.42-5.53170.93-7019.2210003.44301
YMAB | Y-mAbs Therapeutics, Inc.0.80.124.77-18.80142.4376.46-39.70426.5113.799.51-11056.78-4394.66003.8603
IDYA | IDEAYA Biosciences, Inc. 0.740.552.6919.1264.8845.03102.067833.6937.9665.670.00-15297.710011.3119
PACB | Pacific Biosciences of Ca0.74-0.363.1914.5753.6449.68195.5479103.8466.6596.990.00-18829.22007.3161
DNLI | Denali Therapeutics Inc. 0.740.84-1.5212.1030.313.1225.06536.928.806.44-3389.05-7386.06007.15982
TXG | 10x Genomics, Inc. Class 0.73-0.331.17-1.0310.6457.1518.6755113.3556.4339.91-124.65-11115.21008.31209

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-